|
INS
(HGNC:6081)
|
hyperproinsulinemia
(MONDO_0014535)
|
Limited
|
|
|
INPPL1
(HGNC:6080)
|
opsismodysplasia
(MONDO_0009785)
|
Strong
|
|
|
INS
(HGNC:6081)
|
maturity-onset diabetes of the young type 10
(MONDO_0013240)
|
Moderate
|
|
|
ING1
(HGNC:6062)
|
head and neck squamous cell carcinoma
(MONDO_0010150)
|
Limited
|
|
|
IMPG1
(HGNC:6055)
|
adult-onset foveomacular vitelliform dystrophy
(MONDO_0011979)
|
Moderate
|
|
|
IMPG1
(HGNC:6055)
|
retinitis pigmentosa
(MONDO_0019200)
|
Moderate
|
|
|
IMPDH1
(HGNC:6052)
|
retinitis pigmentosa
(MONDO_0019200)
|
Strong
|
|
|
APOA1
(HGNC:600)
|
AApoAI amyloidosis
(MONDO_0019731)
|
Moderate
|
|
|
IMPDH1
(HGNC:6052)
|
inherited retinal dystrophy
(MONDO_0019118)
|
Strong
|
|
|
IMPDH1
(HGNC:6052)
|
Leber congenital amaurosis
(MONDO_0018998)
|
Limited
|
|
|
IMPDH1
(HGNC:6052)
|
Leber congenital amaurosis 11
(MONDO_0013454)
|
Limited
|
|
|
APOB
(HGNC:603)
|
homozygous familial hypercholesterolemia
(MONDO_0018328)
|
Moderate
|
|
|
IL2RG
(HGNC:6010)
|
Omenn syndrome
(MONDO_0011338)
|
Limited
|
|
|
APOB
(HGNC:603)
|
hypercholesterolemia, autosomal dominant, type B
(MONDO_0007751)
|
Definitive
|
|
|
IL7R
(HGNC:6024)
|
Omenn syndrome
(MONDO_0011338)
|
Limited
|
|
|
IL2RA
(HGNC:6008)
|
neonatal diabetes mellitus
(MONDO_0016391)
|
Limited
|
|
|
APOA1
(HGNC:600)
|
hypoalphalipoproteinemia, primary, 2
(MONDO_0032766)
|
Moderate
|
|
|
IL21
(HGNC:6005)
|
common variable immunodeficiency
(MONDO_0015517)
|
Limited
|
|
|
IL2RA
(HGNC:6008)
|
immunodeficiency due to CD25 deficiency
(MONDO_0011664)
|
Strong
|
|
|
ABCC8
(HGNC:59)
|
permanent neonatal diabetes mellitus
(MONDO_0100164)
|
Strong
|
|